Dermira (NASDAQ: DERM) reported Q2 EPS of $0.10, $0.12 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $18.37 million.

For earnings history and earnings-related data on Dermira (DERM) click here.